摘要
目的探讨肺癌患者D-二聚体与肿瘤分期问的关系。方法采用免疫ELISA测定法检测各期别肺癌患者D-二聚体的浓度。结果早期肺癌与晚期肺癌D-二聚体阳性率对照，差别有统计学意义。结论对肺癌患者作定期的D-二聚体检测，早期发现并及时改善凝血功能异常，对肿瘤的发生、发展、及预后有指导性意义。
Objective To Explore the relationship between lung cancer patients with D-dimer and tumor sub-period.Methods By immune ELISA measurement test each period of lung cancer patients they d-dimer concentration.Results The positive rate of early stage lung cancer and advanced lung cancer D-dimer control,the difference was statistically significant.Conclusions Regular D-dimer testing,early detection and timely improved coagulation abnoimalities of tumor occurrence,development,and prognosis of guiding significance in lung cancer patients.
出处
《中国药业》
CAS
2013年第A02期146-146,共1页
China Pharmaceuticals
